openPR Logo
Press release

COVID-19 Diagnostics Market to Reach USD 9.20 Billion in 2028; Increasing R&D Activities to Launch Unique Therapies will Favor Growth: Fortune Business Insights™

08-27-2021 09:06 AM CET | Health & Medicine

Press release from: Fortune Business Insights

COVID-19 Diagnostics Market

COVID-19 Diagnostics Market

The global COVID-19 diagnostics market is set to gain momentum from the increasing research and development activities to create numerous compounds and combinations for the creation of novel coronavirus detection systems and therapies. Biopharma Reporter, for instance, mentioned that the U.S. experienced a surge of 255 therapies in March 2020 against this deadly virus. This information is given by Fortune Business Insights™ in a report, titled, “COVID-19 Diagnostics Market, 2021-2028.” As per the report, the market size was USD 16.05 billion in 2020. It is projected to drop from USD 20.05 billion in 2021 to USD 9.20 billion in 2028 at a CAGR of -10.5% in the forecast period.

Request a Sample Copy of the Research Report:

Instruments Segment to Remain at Forefront Stoked by Adoption of ELISA Instruments
Based on the product type, the market is bifurcated into instruments and reagents & kits. Out of these, the instruments segment remained dominant in 2020 by holding the largest COVID-19 diagnostics market share. This growth is attributable to the surging usage of ELISA instruments and polymerase chain reaction (PCR) analyzers for conducting R&D activities.

Report Coverage-
We aim to provide the best market research solutions under one roof to help our clients choose the best strategy as per their requirements. Our syndicated or custom reports deliver accurate statistics and a comprehensive analysis on revenue. The competitive landscape section contains detailed profiles of prominent organizations. They also include company description, revenue, and sales generated in the COVID-19 diagnostics business.

COVID-19 Pandemic: Development of Molecular and Point-of-care Tests to Aid Growth
The World Health Organization (WHO) declared the COVID-19 pandemic to be a public health emergency in January 2020. The surging development of a large number of diagnostics, such as point-of-care tests and molecular tests because of the increasing number of coronavirus positive patients is expected to drive the demand for coronavirus diagnostics solutions in the near future.

Increasing Prevalence of Communicable Coronavirus Diseases to Drive Growth
The rising prevalence of communicable coronavirus diseases has surged the demand for COVID-19 diagnostics across the globe. The Worldometer statistics, for instance, declared that the number of daily new cases is rising constantly. As of 18th May 2021, around 163,312,429 people were affected by COVID-19, according to the World Health Organization (WHO). Besides, the surging sales of reagents & kits for the detection of this virus are expected to drive the COVID-19 diagnostics market growth in the upcoming years. However, manufacturers have to undergo stringent regulatory restrictions for launching state-of-the-art kits. It may hamper growth.

Presence of Novel Diagnostic Equipment to Help North America Dominate
Geographically, in 2020, North America earned USD 5.28 billion in terms of revenue and would lead the market throughout the forthcoming years. The increasing testing rates to detect the coronavirus and the presence of adequate COVID-19 diagnostic equipment would bolster growth. On the other hand, Europe is anticipated to exhibit a significant CAGR fueled by the utilization of advanced COVID diagnostics technologies for preventing transmission of this deadly virus.

Have Any Query? Ask Our Experts:

Key Players Focus on Receiving Fast Track Approvals to Distribute Their In-house Products
The global market contains a large number of companies that are persistently striving to gain a competitive edge. To do so, they are trying to receive approvals from regulatory bodies for distributing their products in the market. Below are the two notable industry developments:
• May 2020: Quidel received Emergency Use Authorization (EUA) from the U.S. FDA to distribute its rapid point-of-care test named Sofia 2 SARS Antigen FIA for the detection of COVID-19.
• March 2020: The U.S. Food and Drug Administration approved the usage of the first point-of-care test for COVID-19 diagnosis. It will help Americans in providing results within hours, rather than days, unlike the other existing tests.
A list of renowned providers of COVID-19
diagnostics present in the global market:
• Abbott (Illinois, U.S)
• Danaher Corporation (Washington D.C, U.S)
• Siemens Healthcare GmbH (Germany, Europe)
• F. Hoffmann-La Roche Ltd (Switzerland, Europe)
• Quidel Corporation (California, U.S)
• bioMérieux SA (France, Europe)
• Quest Diagnostics Incorporated (New Jersey, U.S)
• Thermo Fisher Scientific Inc. (Massachusetts, U.S)
• PerkinElmer Inc. (Massachusetts, U.S)
• Other Prominent Players

Quick Buy - COVID-19 Diagnostics Market Research Report:

Detailed Table of Content:

• Introduction
o Market Scope
o Market Segmentation
o Market Methodology
o Definitions and Assumptions
• Executive Summary
• Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
• Key Insights
o Overview: Guidelines for COVID-19 Diagnosis
o New Product Launch
o Prevalence of COVID-19 Disease
o Impact of COVID-19 on Diagnostics Market
o Overview of Regulatory Scenario
o Impact on Supply Chain of Diagnostics Amid the Pandemic
o Key Industry Developments - Mergers, Acquisitions, and Partnerships
o Recent Launches/Developments Pertaining to Mobile/On-site COVID-19 Testing
• Global COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2028
o Key Findings / Summary
o Market Analysis, Insights and Forecast – By Product

TOC Continued….

Get your Customized Research Report:

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Fortune Business Insights™
LinkedIn | Twitter | Blogs

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COVID-19 Diagnostics Market to Reach USD 9.20 Billion in 2028; Increasing R&D Activities to Launch Unique Therapies will Favor Growth: Fortune Business Insights™ here

News-ID: 2370444 • Views: 265

More Releases from Fortune Business Insights

Mobility Scooter Market 2021 by Manufacturers, Regions, Type and Application, Fo …
The global mobility scooters market size is expected to gain momentum by reaching USD 1.85 billion while exhibiting a CAGR of 6.9% between 2020 and 2027. This is attributable to the growing focus on developing innovative mobility scooters and the increasing prevalence of neurological disorders across the globe. This information is published by Fortune Business Insights, in its latest report, titled, “Mobility Scooters Market Size, Share & Industry Analysis, By
Surgical Stapling Devices Market Trending Technologies, Development Plans and Fu …
The rising prevalence of chronic diseases is expected to contribute positively to the surgical stapling devices market, says Fortune Business Insights in a report, titled “Surgical Stapling Devices Market Size, Share & Industry Analysis, By Product Type (Powered, Manual), By Type (Disposable, Re-usable), By Application (Gynecology Surgery, Urology Surgery, General Surgery, Others), By Surgery Type (Open Surgery, Laparoscopic Surgery), By End-user (Hospitals, Speciality Clinics, Others) and Regional Forecast, 2019-2026.” The
DNA Sequencing Market | Dynamics, Market Size, Analysis, Development, Revenue, F …
The Global DNA Sequencing Market size is expected to gain momentum backed by the increasing incidence of suicides and the growing number of psychiatrists that is likely to boost the adoption of advanced DNA Sequencing modules worldwide. This information is published by Fortune Business Insights in its upcoming report, titled, ““DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next
Radiofrequency Ablation Systems Market 2021 Global Industry Size Forecast 2027
The increasing prevalence of cancer and rising demand for treating such chronic diseases are propelling the Global Radiofrequency Ablation Systems Market, finds Fortune Business Insights in their recent study. The study is titled, “Radiofrequency Ablation Systems Market: Global Market Analysis, Insights, and Forecasts, 2020 – 2027.” The market, as per study, will exhibit growth at a promising CAGR on account of rising prevalence of both cardiovascular and chronic diseases around the

All 5 Releases

More Releases for COVID

Company Innovation During COVID-19
Centuria Foods, Inc. was able to come out on top during the worldwide COVID-19 pandemic because of its ability to adapt and act quickly to the new normal. The company’s leadership quickly realized this virus was going to be a long term crisis that would result in short term revenue loss. Most clients were wanting to wait and see what was going to happen before moving forward with previously scheduled production.
COVID-19 proof deliveries
DUNA-BIOSHIELD eliminates the risk of contamination without risks for people, residues, odors and without environmental restrictions. It is our hydroalcoholic disinfectant compliant with the directives of the World Health Organization that DUNA has developed, and has been applied since March 2020 to all products departing from its factory in Modena. With the official extension of the state of health emergency on the national territory until October 15th, as well as the
Telehealth Market: Overview The telehealth market is riding on the wave of growth. This is because telehealth is no longer an option, but a necessity due to the increasing dangers of COVID-19. The crisis is serving as an opportunity for the telehealth market to grow at a rapid pace. During this uncertain COVID-19 pandemic, telehealth serves as a boon. With a large populace forced to stay at home due to the
Covid 19 Discounts at Imaginology
Imaginology LLC, a Phoenix owned small business, specializing in animation, video and interactive media production, announced that it is offering discounts on their in-studio, live streaming services to businesses affected by Covid-19. Like the businesses they want to help, their business has also been impacted by the pandemic. The staff saw the broad reaching effects of sheltering in place on businesses and families alike and realized the studio is in
New Delhi, 19 June, 2020 - Business Horizons, pharmaceutical publishers, announces the launch of their latest publication titled Pharma Manufacturing Covid-19 Challenge. This is their latest offering in the field of pharmaceutical books, after the highly successful earlier book Pharmaceutical Facility Management. In December 2019, China began noticing a disturbing trend of pneumonia like cases that were fast multiplying in the city of Wuhan, the sprawling capital of central China’s Hubei
COVID-19 UV Light Solution
New York-based MRD Lighting, a major vendor to the international cruise industry, is developing ultraviolet lighting prototypes to combat airborne and surface-transmitted viruses aboard ships. The company, which has consistently innovated in providing a wide array of solutions to cruise lines, is working with subject matter experts in the radiological and epidemiology arenas to provide rapid-response capabilities as the Coronavirus increasingly impacts the cruise industry. "We have been expanding our capabilities and